Antibes Ventures

Antibes Ventures is a family office and venture capital vehicle that writes first checks into early-stage medical device, diagnostics, and health technology companies. We invest at pre-seed and seed, frequently alongside a lead investor, and reserve capital to follow on as companies reach their next inflection point. What we bring beyond capital is operator experience. Our founder has taken a medical device company from first-in-human through a Nasdaq listing, and that path informs how we help portfolio companies with the questions that decide whether a good technology becomes a real business: — Reimbursement and market access: coding, coverage, and payment strategy built early rather than retrofitted after launch. — Regulatory strategy: 510(k), De Novo, PMA, and Breakthrough Device pathway selection and positioning. — Commercial launch: first-call planning, KOL development, and the transition from clinical evidence to revenue. Antibes Ventures makes first checks in early-stage medical device, diagnostics, and health technology companies. We usually come in at pre-seed or seed, often alongside a lead we trust, and we keep room to follow our best companies into their next round.